文献速递冠心病血脂与心血管预防

冠状动脉移植物失效的机制、后果与预防

Mechanisms, Consequences, and Prevention of Coronary Graft Failure.
PubMed 文献 · Circulation · 2017-01-01

本文综述冠状动脉旁路移植术后移植物失效的发生率、病理生理机制及临床后果。血栓形成、内皮功能障碍、血管痉挛和氧化应激是移植物失效的相关机制,移植物自身特征、靶血管条件、技术因素及全身动脉粥样硬化危险因素共同影响失效风险。移植物失效不一定与不良临床事件相关,术中血流验证及抗血小板和他汀类二级预防有助于降低失效发生率。

要点

  • 移植物失效与血栓形成、内皮功能障碍、血管痉挛和氧化应激相关。
  • 移植物特征、靶血管条件、技术因素及全身危险因素共同决定移植物结局。
  • 术中血流验证及抗血小板、降脂二级预防可帮助减少移植物失效。

核心结论

  • 冠状动脉移植物失效是多因素现象,其发生与移植物自身、靶血管、技术及全身危险因素相关,但失效并不总与不良临床事件相关。
  • 术中血流验证和以抗血小板及降脂药物为基础的二级预防有助于降低移植物失效发生率。

研究设计与样本

  • 综述:总结当前相关证据,概述冠状动脉移植物失效的发生率、病理生理和临床后果。

主要发现

  • 血栓形成、内皮功能障碍、血管痉挛和氧化应激是与移植物失效相关的不同机制。
  • 移植物的内在形态和功能特征在决定失效中起作用。
  • 靶血管特征如狭窄严重程度、直径、动脉粥样硬化负荷范围和既往血管内介入是移植物结局的重要决定因素。
  • 技术因素如移植物获取方法、血管扩张方案、储存液和吻合技术也对移植物成功起主要作用。
  • 全身动脉粥样硬化危险因素如年龄、性别、糖尿病、高血压和血脂异常与移植物失效有不同程度的关联。

临床怎么用

  • 手术时应考虑靶血管特征(狭窄严重程度、直径、动脉粥样硬化负荷、既往介入史)以优化移植物结局。
  • 注意移植物获取方法、血管扩张方案、储存液和吻合技术等技术因素对移植物成功的影响。
  • 术中行血流验证,并采用抗血小板和降脂药物进行二级预防以降低移植物失效发生率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Graft failure occurs in a sizeable proportion of coronary artery bypass conduits. We herein review relevant current evidence to give an overview of the incidence, pathophysiology, and clinical consequences of this multifactorial phenomenon. Thrombosis, endothelial dysfunction, vasospasm, and oxidative stress are different mechanisms associated with graft failure. Intrinsic morphological and functional features of the bypass conduits play a role in determining failure. Similarly, characteristics of the target coronary vessel, such as the severity of stenosis, the diameter, the extent of atherosclerotic burden, and previous endovascular interventions, are important determinants of graft outcome and must be taken into consideration at the time of surgery. Technical factors, such as the method used to harvest the conduits, the vasodilatory protocol, the storage solution, and the anastomotic technique, also play a major role in determining graft success. Furthermore, systemic atherosclerotic risk factors, such as age, sex, diabetes mellitus, hypertension, and dyslipidemia, have been variably associated with graft failure. The failure of a coronary graft is not always correlated with adverse clinical events, which vary according to the type, location, and reason for failed graft. Intraoperative flow verification and secondary prevention using antiplatelet and lipid-lowering agents can help reducing the incidence of graft failure.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Gaudino M, Antoniades C, Benedetto U, et al. Mechanisms, Consequences, and Prevention of Coronary Graft Failure. Circulation. 2017. PMID: 29084780. doi:10.1161/CIRCULATIONAHA.117.027597

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。